ENDEFR
Home › China › 上海迈思强医疗器械有限公司

上海迈思强医疗器械有限公司

企业 · 上海, China · LEI 549300JK4U3MGANCT172
LEI active

Summary

上海迈思强医疗器械有限公司 is registered in China and entered in the “National Enterprise Credit Information Publicity System” under number 913100006929102587. Its legal form is 企业 – enterprise (China). According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 15 of them in China. The LEI was first issued on 14 Nov 2019 and the record was last updated on 15 Jul 2026; the next renewal is due by 3 Aug 2027. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2021, more than 24 months before this data release. The group may have changed since.

Company details

Legal form企业
enterprise (China)
RegisterNational Enterprise Credit Information Publicity System · Register website
Registration number913100006929102587
Registration authorityState Administration for Market Regulation
JurisdictionChina
Registered address上海市长宁区天山西路568号1幢503室, 200335 上海, China
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)10 Aug 2009
LEI549300JK4U3MGANCT172
LEI statusactive
LEI first issued14 Nov 2019
LEI record last updated15 Jul 2026
Next LEI renewal3 Aug 2027
Corroboration of the LEI recordfully corroborated

Group membership

Johnson & Johnson United States ultimate parent
上海迈思强医疗器械有限公司 this entity
View the whole group: 209 subsidiaries in 47 countries

Relationship to the parent

Direct parentUltimate parent
ParentJohnson & JohnsonJohnson & Johnson
Accounting period1 Jan 2021 to 31 Dec 20211 Jan 2021 to 31 Dec 2021
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start3 Nov 20193 Nov 2019
Recorded at GLEIF since3 Nov 20233 Nov 2023
Last updated24 Jul 202524 Jul 2025
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (97)

and 85 more